Literature DB >> 10493908

Enzymic characterization in vitro of recombinant proprotein convertase PC4.

A Basak1, B B Touré, C Lazure, M Mbikay, M Chrétien, N G Seidah.   

Abstract

Proprotein convertase PC4A, a member of the subtilisin/kexin family of serine proteases, was obtained in enzymically active form following expression of vaccinia virus recombinant rat (r)PC4A in GH4C1 cells. It displayed maximal activity at pH 7.0 and a Ca(2+) concentration of 2.0 mM. Using PC4-specific antibodies, Western blot analysis of the medium revealed a major band at approximately 54 kDa, corresponding to the molecular size of mature rPC4A. Among the various peptidyl-[4-methylcoumarin 7-amide (MCA)] substrates tested, the one that was preferred the most by rPC4A was acetyl (Ac)-Arg-Lys-Lys-Arg-MCA, which is cleaved 9 times faster (as judged from V(max)/K(m) measurements) than the best furin and PC1 substrate, pGlu-Arg-Thr-Lys-Arg-MCA. Recombinant rPC4A, along with human (h)furin and hPC1, cleaved a 17-amino-acid synthetic peptide, YQTLRRRVKR downward arrowSLVVPTD (where downward arrow denotes site of cleavage, and the important basic residues are shown in bold), encompassing the junction between the putative pro-segment of rPC4A and the active enzyme, suggesting a possible auto-activation of the enzyme. In an effort to identify potential physiological substrates for PC4, studies were performed with pro-[insulin-growth-factor (IGF)]-derived synthetic peptides, namely Ac-PAKSAR downward arrowSVRA (IGF-I(66-75)) and Ac-PAKSER downward arrowDVST (IGF-II(63-72)), as well as two lysine mutants [(IGF-I(66-75)Lys(70)) and (IGF-II(63-72)Lys(67))]. Unlike PC1 and furin, rPC4A cleaved efficiently both IGF-I(66-75) and IGF-II(63-72), suggesting a possible role of PC4 in the maturation of IGF-I and -II. In contrast, the peptides with a position 2 (P2) lysine mutation, IGF-I(66-75)Lys(70) and IGF-II(63-72)Lys(67), were cleaved more efficiently by PC1 and furin compared with rPC4A. Furthermore, using synthetic peptides containing the processing sites of pituitary adenylate-cyclase-activating polypeptide (PACAP)-38, we were able to confirm that, of the two testicular enzymes PC4 and PC7, PC4 is the best candidate enzyme for maturation of PACAP. Our data suggest that rPC4A is a functionally active convertase, with a substrate specificity somewhat different from that of other convertases, namely KXXR downward arrow (where X denotes any other residue). As expected, p-chloromercuribenzoic acid and metal chelators such as EDTA, EGTA and trans-1,2-diaminocyclohexane-N,N,N', N'-tetraacetic acid inhibit the proteolytic activity of rPC4A, whereas it is activated by dithiothreitol. PC4A was also inhibited by transition-metal ions (Cu(2+)>Hg(2+)>Zn(2+) Ni(2+)>Co(2+)), as well as by small peptide semicarbazones (SCs), such as Arg-Lys-Lys-Arg-SC (K(i) 0.75 microM) and Arg-Ser-Lys-Arg-SC (K(i) 11.4 microM).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10493908      PMCID: PMC1220520     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

Review 2.  Immunization with DNA.

Authors:  J J Donnelly; J B Ulmer; M A Liu
Journal:  J Immunol Methods       Date:  1994-12-02       Impact factor: 2.303

3.  Testis-specific prohormone convertase PC4 processes the precursor of pituitary adenylate cyclase-activating polypeptide (PACAP).

Authors:  M Li; K Nakayama; Y Shuto; A Somogyvari-Vigh; A Arimura
Journal:  Peptides       Date:  1998       Impact factor: 3.750

4.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r).

Authors:  J P Liu; J Baker; A S Perkins; E J Robertson; A Efstratiadis
Journal:  Cell       Date:  1993-10-08       Impact factor: 41.582

5.  Structure of the gene for the testis-specific proprotein convertase 4 and of its alternate messenger RNA isoforms.

Authors:  M Mbikay; M L Raffin-Sanson; H Tadros; F Sirois; N G Seidah; M Chretien
Journal:  Genomics       Date:  1994-03-15       Impact factor: 5.736

6.  Developmental expression of the prohormone convertases PC1 and PC2 in mouse pancreatic islets.

Authors:  M Marcinkiewicz; D Ramla; N G Seidah; M Chrétien
Journal:  Endocrinology       Date:  1994-10       Impact factor: 4.736

7.  Amyloid precursor protein is not processed by furin, PACE 4, PC1/3, PC2, PC4 and PC5/6 of the furin family of proprotein processing enzymes.

Authors:  B De Strooper; J W Creemers; D Moechars; D Huylebroeck; W J Van De Ven; F Van Leuven; H Van den Berghe
Journal:  Biochim Biophys Acta       Date:  1995-01-19

8.  Insulin-like growth factor-I mRNA expression in the interstitial cells of the rat testis.

Authors:  A Moore; C L Chen; J R Davis; I D Morris
Journal:  J Mol Endocrinol       Date:  1993-12       Impact factor: 5.098

9.  Insulin-like growth factor-binding protein-2: the effect of human chorionic gonadotropin on its gene regulation and protein secretion and its biological effects in rat Leydig cells.

Authors:  D Wang; M L Nagpal; T Lin; S Shimasaki; N Ling
Journal:  Mol Endocrinol       Date:  1994-01

Review 10.  The proprotein convertases.

Authors:  D F Steiner
Journal:  Curr Opin Chem Biol       Date:  1998-02       Impact factor: 8.822

View more
  11 in total

1.  Substrate cleavage analysis of furin and related proprotein convertases. A comparative study.

Authors:  Albert G Remacle; Sergey A Shiryaev; Eok-Soo Oh; Piotr Cieplak; Anupama Srinivasan; Ge Wei; Robert C Liddington; Boris I Ratnikov; Amelie Parent; Roxane Desjardins; Robert Day; Jeffrey W Smith; Michal Lebl; Alex Y Strongin
Journal:  J Biol Chem       Date:  2008-05-27       Impact factor: 5.157

2.  Role of pro-IGF-II processing by proprotein convertase 4 in human placental development.

Authors:  Qing Qiu; Ajoy Basak; Majambu Mbikay; Benjamin K Tsang; Andrée Gruslin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-22       Impact factor: 11.205

Review 3.  Inhibitors of proprotein convertases.

Authors:  Ajoy Basak
Journal:  J Mol Med (Berl)       Date:  2005-10-08       Impact factor: 4.599

Review 4.  The biology and therapeutic targeting of the proprotein convertases.

Authors:  Nabil G Seidah; Annik Prat
Journal:  Nat Rev Drug Discov       Date:  2012-05       Impact factor: 84.694

5.  Alteration in the processing of the ACRBP/sp32 protein and sperm head/acrosome malformations in proprotein convertase 4 (PCSK4) null mice.

Authors:  Steve Tardif; Benoit Guyonnet; Nathaly Cormier; Gail A Cornwall
Journal:  Mol Hum Reprod       Date:  2012-02-21       Impact factor: 4.025

6.  In vitro elucidation of substrate specificity and bioassay of proprotein convertase 4 using intramolecularly quenched fluorogenic peptides.

Authors:  Sarmistha Basak; Michel Chrétien; Majambu Mbikay; Ajoy Basak
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

Review 7.  Neuropeptides of the pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide/growth hormone-releasing hormone/secretin family in testis.

Authors:  Min Li; Akira Arimura
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

8.  Identification of Lys-Pro-Gln as a novel cleavage site specificity of saliva-associated proteases.

Authors:  Eva J Helmerhorst; Xiuli Sun; Erdjan Salih; Frank G Oppenheim
Journal:  J Biol Chem       Date:  2008-05-07       Impact factor: 5.157

9.  Pituitary adenylate cyclase activating polypeptide-mediated intracrine signaling in the testicular germ cells.

Authors:  Min Li; Hisayuki Funahashi; Majambu Mbikay; Seiji Shioda; Akira Arimura
Journal:  Endocrine       Date:  2004-02       Impact factor: 3.633

10.  Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV.

Authors:  John T-A Hsu; Chih-Jung Kuo; Hsing-Pang Hsieh; Yeau-Ching Wang; Kuo-Kuei Huang; Coney P-C Lin; Ping-Fang Huang; Xin Chen; Po-Huang Liang
Journal:  FEBS Lett       Date:  2004-09-10       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.